Standout Papers

A Phase II Trial of Tideglusib in Alzheimer's Disease 2015 2026 2018 2022 384
  1. A Phase II Trial of Tideglusib in Alzheimer's Disease (2015)
    Simon Lovestone, Merçé Boada et al. Journal of Alzheimer s Disease

Immediate Impact

1 by Nobel laureates 13 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
CGRP sensory neurons promote tissue healing via neutrophils and macrophages
2024 StandoutNature
3 intermediate papers

Works of Michael Hüll being referenced

Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load
2006
Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 β and interleukin-6 in human monocytes: a re-examination
1996
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael Hüll 725 349 572 364 39 1.5k
Sethu Sankaranarayanan 755 208 469 310 37 1.4k
Kristin R. Wildsmith 822 158 611 270 39 1.5k
Lee‐Way Jin 1015 190 677 416 39 1.7k
Hitoshi Tanimukai 1152 342 979 315 54 2.2k
L. Fernández‐Novoa 636 327 429 540 72 1.6k
Ghania Ait‐Ghezala 611 218 714 424 61 1.9k
Nikunj Patel 791 205 579 478 25 1.5k
Jie Zhao 1035 341 498 352 38 1.7k
Jessica L. Restivo 1071 272 669 446 14 1.8k
Melissa Freeman 904 227 420 512 21 1.4k

All Works

Loading papers...

Rankless by CCL
2026